LEVETIRACETAM
| Brand name | KEPPRA |
|---|---|
| Active ingredient | LEVETIRACETAM |
| Strength | 250MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | November 1999 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8802142*PED | December 2031 | — |
| 8802142 | June 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.